Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Garima

      Articles By : Garima

      AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

      AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

      Garima29 March 2019 9:15 AM IST
      Under the deal, AstraZeneca will pay Daiichi up to $6.9 billion, including a $1.35 billion upfront payment. The two companies will share development...
      SL Raheja Hospital launches Institute of Digestive and Liver Care

      SL Raheja Hospital launches Institute of Digestive and Liver Care

      Garima28 March 2019 10:30 AM IST
      Mumbai: Aiming to provide comprehensive Digestive Care services to patients who are faced with gastrointestinal problems, Institute of Digestive and...
      Newly approved MS drug Mayzent priced at USD 88000: Novartis

      Newly approved MS drug Mayzent priced at USD 88000: Novartis

      Garima28 March 2019 10:00 AM IST
      Novartis has priced the treatment at $88,000 annually, head of pharmaceuticals Paul Hudson told Reuters, a level exceeding some other MS drugs and one...
      Amrapali Hospital Auction: Only One Single bid of Rs 13.74 crore made, rejected

      Amrapali Hospital Auction: Only One Single bid of Rs 13.74 crore made, rejected

      Garima27 March 2019 4:55 PM IST
      New Delhi: Troubled Amrapali Group is in for another setback as the Debt Recovery Tribunal (DRT) has rejected the LONE BID of Rs 13.74 crore that was...
      Netmeds acquires health tech startup KiViHealth with Rs 70 crore investment commitment

      Netmeds acquires health tech startup KiViHealth with Rs 70 crore investment commitment

      Garima26 March 2019 10:10 AM IST
      Netmeds didn't disclose the deal value but said it will invest about $10 million (Rs 70 crore) to grow the healthcare business of KiViHealth.Chennai:...
      Fujifilm India joins hands with Yashoda Super Speciality Hospital Kaushambi to end TB together

      Fujifilm India joins hands with Yashoda Super Speciality Hospital Kaushambi to end TB together

      Garima26 March 2019 9:30 AM IST
      Fujifilm India gears up to shoot down Tuberculosis with Yashoda Speciality Hospital KaushambiNew Delhi: Fujifilm India Pvt Ltd, a leader in the...
      Biogen announces $5 billion buyback days after shelving Alzheimers trials

      Biogen announces $5 billion buyback days after shelving Alzheimers trials

      Garima26 March 2019 9:25 AM IST
      Biogen had lost more than $18 billion of its value last week after the company and partner Eisai Co Ltd ended two late-stage trials of their...
      Court allows ED to seek assistance from 21 countries in Sterling Biotech bank fraud case

      Court allows ED to seek assistance from 21 countries in Sterling Biotech bank fraud case

      Garima25 March 2019 12:25 PM IST
      New Delhi: A Delhi court has allowed the Enforcement Directorate to send letters rogatory (LR) to 21 countries, involving the UK and the UAE, seeking...
      Thermo Fisher to acquire Brammer Bio in 1.7 Billion Dollar deal

      Thermo Fisher to acquire Brammer Bio in 1.7 Billion Dollar deal

      Garima25 March 2019 12:18 PM IST
      Thermo Fisher to acquire Brammer Bio in 1.7 Billion Dollar dealUS Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments,...
      Smiths Group to list struggling healthcare unit

      Smiths Group to list struggling healthcare unit

      Garima24 March 2019 9:20 AM IST
      Smiths Group's medical business was valued between 2.3 billion pounds and 2.8 billion pounds by some analysts in September when the two companies...
      Jury finding upends Bayer Roundup defense strategy-Experts

      Jury finding upends Bayer Roundup defense strategy-Experts

      Garima24 March 2019 9:00 AM IST
      "The fact that Bayer lost this trial despite it being set up in the most favourable way for them is a huge setback," said Thomas Rohback, a...
      Syngene International wins CMO Leadership Awards

      Syngene International wins CMO Leadership Awards

      Garima23 March 2019 9:45 AM IST
      Syngene was successfully rated across the six categories - Capabilities, Compatibility, Expertise, Quality, Reliability and Service – that were used...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok